CTMX
CytomX Therapeutics (CTMX)
$60
About CytomX Therapeutics (CTMX)
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Details
Daily high
$0.62
Daily low
$0.57
Price at open
$0.61
52 Week High
$5.85
52 Week Low
$0.57
Market cap
48.0M
Dividend yield
0.00%
Volume
42,084
Avg. volume
3.6M
P/E ratio
1.52
CytomX Therapeutics News
Details
Daily high
$0.62
Daily low
$0.57
Price at open
$0.61
52 Week High
$5.85
52 Week Low
$0.57
Market cap
48.0M
Dividend yield
0.00%
Volume
42,084
Avg. volume
3.6M
P/E ratio
1.52